According to Xconomy, Biomark Capital has spun off from Burill Capital Fund IV. The new venture firm has offices in Greenwich, Conn., Moscow and San Francisco. The site reported that Biomark Capital will continue to run Burrill Capital fourth fund’s existing portfolio and is seeking to raise additional financing by the end of the year. Biomark investment team is made up of David Wetherell, Douglas Lind, Bryant Fong, Joshua Zelig, Sergey Axenovich, and Janos Redei as an entrepreneur-in-residence. Burrill Capital’s fourth fund has raised $200 million.